Skip to main content

Kaleido Biosciences, Inc.

KLDODelisted Apr 18, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001751299

Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Kaleido Biosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of KLDO: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders71710
Shares34.3M34.7M+344.5K (+1.0%)
Value$277.9M$257.8M−$20.1M (−7.2%)

New holders (13)

Institutions that held Kaleido Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to KLDO in Q2 2021
InstitutionSharesValue% of portfolio
Parametric Portfolio Associates LLC105,910$788.0K0.00%
IHT Wealth Management, LLC19,320$144.0K0.01%
ProShare Advisors LLC12,665$94.0K0.00%
Rhumbline Advisers10,842$81.0K0.00%
D. E. Shaw & Co., Inc.10,483$78.0K0.00%
Texas Yale Capital Corp.10,000$74.0K0.00%
Advisor Group Holdings, Inc.3,753$28.0K0.00%
State of Wyoming2,112$16.0K0.01%
Simplex Trading, LLC749$5.00K0.00%
Laurel Wealth Advisors LLC625$5.00K0.00%
Captrust Financial Advisors598$4.00K0.00%
Salem Investment Counselors Inc125$1.00K0.00%
Advisory Services Network, LLC90$1.00K0.00%

Sold out (13)

Institutions that held Kaleido Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.